Trump Administration May Relax Supplement Industry Oversight, But Heighten Trade Concerns
This article was originally published in The Rose Sheet
Supplement industry trade associations see positives in working with President-elect Trump, including his focus on business, but they also express concern with the possibility of restrictive trade prospects.
You may also be interested in...
Any movement to advance proposed cosmetics reform legislation could be seen as running counter to President Trump's executive orders earlier this year, which now have FDA centers seeking "broad public comment" on how to achieve "meaningful burden reduction."
CFSAN and other FDA centers ask for "broad public comment" the agency will use "to guide our initial review of our regulations" required in President Trump's January executive order for federal agencies to "evaluate existing regulations and identify those that may merit repeal, replacement, or modification."
Herbalife is the focus of a Securities and Exchange Commission investigation into anti-corruption compliance in the firm’s China business, the company reported in a Jan. 20 regulatory filing. An analyst covering the stock believes the investigation will have little impact on growth.